Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(22%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
1
11%
Ph not_applicable
5
56%
Ph early_phase_1
1
11%
Ph phase_3
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(3)
Other(2)

Detailed Status

Completed3
Recruiting2
Not yet recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 31 (12.5%)
Phase 41 (12.5%)
N/A5 (62.5%)

Trials by Status

recruiting222%
completed333%
not_yet_recruiting222%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9